Expectant mothers might not need to worry about a glass of wine, according to new research published in Obstetrics & Gynecology.
Expectant mothers might not need to worry about a glass of wine, according to new research published in Obstetrics & Gynecology.
Researchers at Cork University Maternity Hospital studied data from 5628 nulliparous pregnant participants, who had been recruited to a prospective cohort study, the Screening for Pregnancy Endpoints study. The women were interviewed at 15 weeks’ gestation and submitted a questionnaire about their alcohol intake before and during the pregnancy.
Occasional alcohol consumption-1 to 2 alcohol units per week-was reported by 1090 (19%) of the participants and low alcohol consumption-3 to 7 units per week-was reported by 1383 (25%) of women. Three hundred (5%) reported heavy alcohol consumption (>14 units per week). Roughly a third of the participants (n = 1905) reported binge consumption, meaning drinking 6 or more alcohol units in one sitting, in the 3 months prior to pregnancy and 23% (n = 1288) indicated that they had binged on alcohol at some point during the first 15 weeks of pregnancy.
Altered odds for small-for-gestational age infant, reduced birth weight, preeclampsia, or spontaneous preterm delivery were not seen in women who consumed alcohol during early pregnancy, even those who reported heavy or binge consumption. The study’s authors stressed that although no adverse effects were seen in the study, no level of alcohol consumption during pregnancy is proven safe.
What do you think of this study? Will you be using it to reassure patients who consumed alcohol before discovering their pregnancy? Alternatively, do you find that these sorts of studies only confuse your patients?
To get weekly advice for today's Ob/Gyn, subscribe to the Contemporary Ob/Gyn Special Delivery.
Maternal sFLT1 and EDN1 linked to late-onset preeclampsia
November 25th 2024A new study highlights the association of maternal soluble Fms-like tyrosine kinase 1 and endothelin 1 with preeclampsia severity, offering insights into the pathogenesis of early- and late-onset forms of the condition.
Read More
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More